Based on the hypothesis that both ATM and MRE11 are integral to the detection of DNA damage and subsequent intracellular signalling following radiotherapy, and hence their deficiency would equate to increased radiosensitivity, we established a two-marker panel of ATM and MRE11 expression by binary regression analysis of tumor samples and normal tissues. The gene discussed is MRE11; the disease is neoplasm.